Markets:

Overview

News

Currencies

International

Treasuries

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

2.020 -0.090 (-4.27%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Enveric Biosciences, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 22, 2023

Via Benzinga

Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

May 22, 2023

Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share.

Via Benzinga

Enveric Releases Paper Detailing The Development Of Novel Psilocin Prodrugs For The Treatment Of Mental Health Disorders ↗

May 22, 2023

Enveric Biosciences, Inc. (NASDAQ: ENVB) has announced new research results detailing the development of novel psilocin prodrug derivatives targeting treatment of mental health disorders. A manuscript...

Via Benzinga

Why Is Enveric Biosciences (ENVB) Stock Up 120% Today? ↗

May 18, 2023

Enveric Biosciences’ Notice of Allowance for a therapeutic patent is bolstering ENVB stock, but investors should exercise caution.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 19, 2023

Via Benzinga

Why DXC Technology Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket ↗

May 19, 2023

Gainers Monogram Orthopaedics Inc. (NASDAQ: MGRM) shares surged 163.7% to $30.98 in pre-market trading after jumping 62% on Thursday. Monogram Orthopaedics raised $17,216,147 through the sale of...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

May 19, 2023

It's time to start off the final day of the trading week with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

Dow Tumbles 150 Points; Alibaba Earnings Top Views ↗

May 18, 2023

U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 150 points on Thursday. The Dow traded down 0.48% to 33,259.03 while the NASDAQ rose 0.63% to 12,579.41. The S&P...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 18, 2023

Via Benzinga

Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

May 18, 2023

Gainers CaliberCos Inc. (NASDAQ: CWD) shares jumped 65.6% to $9.94 amid post-IPO volatility.

Via Benzinga

Nasdaq Surges 100 Points; Walmart Raises Full-Year Outlook ↗

May 18, 2023

U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.09% to 33,451.95 while the NASDAQ rose 0.79% to 12,599.66. The S&P...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 18, 2023

Via Benzinga

Enveric Biosciences Receives Notice Of Allowance From US Patent And Trademark Office For Novel Prodrug Of Psilocin ↗

May 18, 2023

Enveric Biosciences, Inc. (NASDAQ: ENVB) has received a notice of allowance from the United States Patent and Trademark Office for a patent application involving EB-373, th

Via Benzinga

Enveric Biosciences Q1 Net Loss Of $4.80M, More On Basic And Diluted Loss Per Share ↗

May 15, 2023

Enveric Biosciences, Inc. (NASDAQ: ENVB) released its corporate update and reported financial results for the first quarter of 2023 ending March 31, 2023.

Via Benzinga

EXCLUSIVE: Fireside With Enveric Biosciences's Dr. Tucker, Unlocking Psychedelic Healing Benefits ↗

April 20, 2023

Recently, at the Benzinga Psychedelic Capital Conference, leading experts from the biotech and pharmaceutical industry gathered to discuss the remarkable potential of psychedelics in medicine.

Via Benzinga

EXCLUSIVE: Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key' ↗

April 14, 2023

Experts gathered at the Benzinga Psychedelics Capital Conference in Miami Beach on Thursday where they talked about revolutionizing psychedelic therapy as a promising new approach for treating mental...

Via Benzinga

What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry ↗

April 03, 2023

The world of psychedelics is evolving rapidly, and the Benzinga Psychedelics Capital Conference is the premier event for those who want to be part of this exciting journey.

Via Benzinga

Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More ↗

March 27, 2023

Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses

Via Benzinga

Enveric Creates Subsidiary Down Under To Further Next-Generation Psychedelics Program ↗

March 21, 2023

Drug development biotech company Enveric Biosciences (NASDAQ: ENVB) has created Australia-based subsidiary Enveric Therapeutics Pty. Ltd. to support the progress of its next-generation psychedelics...

Via Benzinga

Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More ↗

March 20, 2023

Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered

Via Benzinga

Enveric Biosciences: Novel Next-Gen Drug Discovery Platform Includes Rare Toad Enzyme ↗

March 14, 2023

Biopharma company Enveric Biosciences (NASDAQ: ENVB) has shared new findings involving the first-ever isolation of a specific enzyme from the cane toad, plus the successful development of a...

Via Benzinga

Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More ↗

March 13, 2023

Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial

Via Benzinga

Who's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In Person ↗

March 08, 2023

This year’s edition of the Benzinga Psychedelics Capital Conference, THE place to be for those interested or already involved in the space, will take place on April 13, following our established...

Via Benzinga

Here Are The Year's Highest Priced Psychedelics Stocks In US Markets ↗

March 06, 2023

After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.

Via Benzinga

The 7 Most Promising Psychedelic Stocks to Buy in February ↗

February 05, 2023

These psychedelics stocks to buy belong to pre-revenue firms which could potentially blow-up in line with the burgeoning sector.

Via InvestorPlace

What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways ↗

January 03, 2023

What a year for psychedelics!

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 21, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 08, 2022

Via Benzinga

15 Global Psychedelics Executives To Keep An Eye On In 2022 ↗

October 28, 2022

As the global psychedelics industry booms, with companies going public, major financings being announced, and celebrities and big investors getting on board, Benzinga has decided to put together a list...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 29, 2022

Gainers

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

Headline News about Enveric Biosciences, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today